Mary E Law

11PUBLICATIONS
70CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous systemCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 21, 2026
CerS2 Is a Druggable Target in Triple-Negative Breast Cancer.

|Aug 28, 2025
Non-Canonical, Strongly Selective Protein Disulfide Isomerases as Anticancer Therapeutic Targets.

Mary E Law, Zaafir M Dulloo, Brian Hardy

|Jun 25, 2025
The Role of Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Signaling in Cancer.

Sourajeet Karfa, Shashank Saurav, Bryan Feng

|Mar 19, 2025
DR5 Disulfide Bonding Functions as a Sensor and Effector of Protein Folding Stress.

Mary E Law, Zaafir M Dulloo, Samantha R Eggleston

|Mar 18, 2024
DR5 disulfide bonding as a sensor and effector of protein folding stress.

Mary E Law, Zaafir M Dulloo, Samantha R Eggleston

Pageof 2